Successful treatment of thyrotoxicosis is accompanied by a decrease in serum sclerostin levels
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-6614
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Successful treatment of thyrotoxicosis is accompanied by a decrease in serum sclerostin levels ; volume:5 ; number:1 ; day:13 ; month:11 ; year:2012 ; pages:1-3 ; date:12.2012
Thyroid research ; 5, Heft 1 (13.11.2012), 1-3, 12.2012
- Urheber
-
Skowrońska-Jóźwiak, Elżbieta
Krawczyk-Rusiecka, Kinga
Lewandowski, Krzysztof C.
Adamczewski, Zbigniew
Lewiński, Andrzej
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1756-6614-5-14
- URN
-
urn:nbn:de:101:1-2021082907121251269607
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Skowrońska-Jóźwiak, Elżbieta
- Krawczyk-Rusiecka, Kinga
- Lewandowski, Krzysztof C.
- Adamczewski, Zbigniew
- Lewiński, Andrzej
- SpringerLink (Online service)
Ähnliche Objekte (12)
Serum sclerostin levels in osteoporotic fracture patients
Effect of Vitamin D Treatment on Serum Sclerostin Level
Association of Serum Sclerostin with Bone Sclerostin in Chronic Kidney Disease is Lost in Glucocorticoid Treated Patients
Anti-Sclerostin Antibody Inhibits Internalization of Sclerostin and Sclerostin-Mediated Antagonism of Wnt/LRP6 Signaling
Serum sclerostin levels in renal cell carcinoma patients with bone metastases
Serum sclerostin in high-activity adult patients with juvenile idiopathic arthritis
Serum sclerostin is an independent predictor of mortality in hemodialysis patients
Serum level of sclerostin and vitamin D in children with epilepsy
Serum sclerostin and sympathetic skin response: relationship with myeloma bone disease
Sclerostin and Cardiovascular Disease
Serum levels of sclerostin reflect altered bone microarchitecture in patients with hepatic cirrhosis
How Accurate is Your Sclerostin Measurement? Comparison Between Three Commercially Available Sclerostin ELISA Kits
Serum sclerostin levels in osteoporotic fracture patients
Effect of Vitamin D Treatment on Serum Sclerostin Level
Association of Serum Sclerostin with Bone Sclerostin in Chronic Kidney Disease is Lost in Glucocorticoid Treated Patients
Anti-Sclerostin Antibody Inhibits Internalization of Sclerostin and Sclerostin-Mediated Antagonism of Wnt/LRP6 Signaling
Serum sclerostin levels in renal cell carcinoma patients with bone metastases
Serum sclerostin in high-activity adult patients with juvenile idiopathic arthritis
Serum sclerostin is an independent predictor of mortality in hemodialysis patients
Serum level of sclerostin and vitamin D in children with epilepsy
Serum sclerostin and sympathetic skin response: relationship with myeloma bone disease
Sclerostin and Cardiovascular Disease
Serum levels of sclerostin reflect altered bone microarchitecture in patients with hepatic cirrhosis
How Accurate is Your Sclerostin Measurement? Comparison Between Three Commercially Available Sclerostin ELISA Kits
Serum sclerostin levels in osteoporotic fracture patients
Effect of Vitamin D Treatment on Serum Sclerostin Level
Association of Serum Sclerostin with Bone Sclerostin in Chronic Kidney Disease is Lost in Glucocorticoid Treated Patients
Anti-Sclerostin Antibody Inhibits Internalization of Sclerostin and Sclerostin-Mediated Antagonism of Wnt/LRP6 Signaling
Serum sclerostin levels in renal cell carcinoma patients with bone metastases
Serum sclerostin in high-activity adult patients with juvenile idiopathic arthritis
Serum sclerostin is an independent predictor of mortality in hemodialysis patients
Serum level of sclerostin and vitamin D in children with epilepsy
Serum sclerostin and sympathetic skin response: relationship with myeloma bone disease
Sclerostin and Cardiovascular Disease
Serum levels of sclerostin reflect altered bone microarchitecture in patients with hepatic cirrhosis